THERAPEUTIC STRATEGY BASED ON SEMIQUANTITATIVE BCR-ABL PCR FOR MOLECULAR OR CYTOGENETIC RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML)

Authors
SCHLEUNING M BRUMME V WILMANNS W KOLB HJ
Citation
M. Schleuning et al., THERAPEUTIC STRATEGY BASED ON SEMIQUANTITATIVE BCR-ABL PCR FOR MOLECULAR OR CYTOGENETIC RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML), Experimental hematology, 25(8), 1997, pp. 622-622
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
Experimental hematology → ACNP
ISSN journal
0301472X
Volume
25
Issue
8
Year of publication
1997
Pages
622 - 622
Database
ISI
SICI code
0301-472X(1997)25:8<622:TSBOSB>2.0.ZU;2-H